Elective single embryo transfer for Canadian women under 35 most efficacious and cost-effective option

Many Canadian couples battling infertility turn to in vitro fertilization (IVF) to have a child. In Canada, IVF is not publicly funded, making the decision on the number of embryos to be transferred more complicated than in many European countries which link funding to elective single embryo transfer (eSET).

The joint clinical practice guideline, developed by the Society of Obstetricians and Gynaecologists of Canada (SOGC) and the Canadian Fertility and Andrology Society (CFAS), provides valuable insight to help guide that decision-making process.

The authors highlight the need for awareness and understanding of the various in vitro fertilization options available to Canadians, the burden of multiple birth pregnancies, the impact of a mother's age on the probability of success of IVF treatments, and the importance of public funding to reduce the main barrier to the adoption of elective single embryo transfer for both physicians and patients.

This guideline advances recommendations with a goal to reduce the incidence of multiple births in at-risk populations, while maintaining acceptable live birth rates. The conclusion: elective single embryo transfer for women under 35 with a good prognosis is the most efficacious and cost-effective option for Canadians.

Despite the lack of funding, it remains crucial to significantly reduce the number of IVF multiple pregnancies. In order to have the greatest impact in promoting the uptake of elective single embryo transfer, public funding of IVF must be provided.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
AI system BELA revolutionizes assessment of IVF embryos